Can lisinopril (angiotensin‑converting‑enzyme inhibitor) cause spots or rash on the legs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lisinopril Cause Spots on Legs?

Yes, lisinopril can cause spots or rash on the legs, though this is an uncommon adverse effect that occurs in approximately 2% of patients, with more serious cutaneous reactions like vasculitis being rare.

Spectrum of Cutaneous Reactions to Lisinopril

ACE inhibitors like lisinopril are associated with a broad range of skin manifestations. The overall incidence of adverse effects to ACE inhibitors is estimated at 28%, with approximately half occurring in the skin 1. These cutaneous reactions can mimic various skin diseases and should be considered when sudden, unexplainable skin eruptions appear 1.

Common Cutaneous Manifestations

The skin reactions associated with lisinopril include:

  • Generalized rashes affecting various body parts including the legs, occurring in approximately 2% of patients 2
  • Pruritus (itching), which can affect up to 15% of patients taking ACE inhibitors 2
  • Urticaria (hives) 1
  • Photosensitivity reactions 1
  • Bullous eruptions (blistering) 1

Serious Cutaneous Reactions

More concerning reactions that can present with spots or lesions on the legs include:

  • Cutaneous vasculitis: This presents as a painful, symmetrical purpuric (purple-red spots) eruption, often affecting the feet and lower legs 3. While rare, this can develop within days of starting the medication and may require steroid therapy 3.
  • Angioedema: Though typically affecting the face and lips, this life-threatening reaction occurs in fewer than 1% of patients and is more frequent in Black patients 4

Clinical Evaluation Approach

When evaluating spots on the legs in a patient taking lisinopril, look for:

  • Timing: Drug-induced rashes typically develop within days to weeks after starting medication 5
  • Distribution: Note whether the rash is symmetrical and whether it affects both legs 3
  • Characteristics: Determine if the spots are purpuric (non-blanching), urticarial (raised, itchy), or photodistributed 1
  • Associated symptoms: Assess for pain, pruritus, or systemic symptoms 3

Management Strategy

For Mild Rash

  • Continue lisinopril with close monitoring if the rash is mild and non-progressive 5
  • Consider topical therapies such as moisturizers or low-potency corticosteroids 5
  • Rule out other causes of rash before attributing to lisinopril 1

For Moderate to Severe Rash

  • Temporarily discontinue lisinopril if the rash is progressive, painful, or accompanied by systemic symptoms 5, 3
  • Perform a full vasculitis workup if purpuric lesions are present 3
  • Consider systemic corticosteroids for significant reactions, particularly vasculitis 3
  • If the rash resolves, rechallenge may be attempted at a lower dose with careful monitoring, though this should be avoided if vasculitis was confirmed 5

For Life-Threatening Reactions

  • Permanently discontinue lisinopril if angioedema or bullous/exfoliative eruptions occur 4, 1
  • Do not rechallenge with any ACE inhibitor if angioedema has occurred 4
  • Exercise extreme caution when substituting an ARB, as cross-reactivity can occur 4

Important Clinical Caveats

Previous tolerance does not guarantee future safety: A patient who previously tolerated one ACE inhibitor (like lisinopril) can still develop cutaneous vasculitis with another ACE inhibitor from the same class 3. This means that prior successful treatment with lisinopril does not rule out future adverse cutaneous reactions.

Consider alternative causes: Before attributing skin lesions to lisinopril, exclude other common causes such as venous stasis dermatitis, contact dermatitis, or other concurrent medications 1.

Risk factors for cutaneous reactions include higher doses, drug interactions (particularly with CYP3A4 inhibitors), dehydration, and concurrent use of other medications 4, 5.

References

Research

Cutaneous vasculitis secondary to ramipril.

Journal of drugs in dermatology : JDD, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rosuvastatin-Associated Skin Rash

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is a suitable add-on medication for a patient in their 70s with uncontrolled hypertension on lisinopril (ACEI) 40mg, considering they have lymphedema?
Which of the following medications: Glipizide, Atorvastatin, Lisinopril, Aspirin, Farxiga (Dapagliflozin) is most likely to cause edema?
What is the most appropriate management for a 54-year-old woman with hypertension, chronic kidney disease (CKD), and impaired renal function, who developed hyperkalemia and worsening renal function after initiating lisinopril (angiotensin-converting enzyme inhibitor) and is currently on amlodipine (calcium channel blocker)?
What are the most effective antihypertensive options to add for a 60-year-old male with uncontrolled hypertension on amlodipine (calcium channel blocker) 10mg and lisinopril-hctz (hydrochlorothiazide, angiotensin-converting enzyme inhibitor and diuretic) 40-25?
What to do with elevated Blood Urea Nitrogen (BUN) and creatinine levels after stopping lisinopril (angiotensin-converting enzyme inhibitor)?
In an 80‑year‑old female nursing‑home resident who sustained a fall and now has a traumatic intracranial hematoma while taking aspirin 325 mg daily, should the aspirin be held?
How do postoperative sensations differ between internal anal sphincter hypertonicity and nerve injury or scar‑related sensory alteration after hemorrhoidectomy?
What are the available tablet strengths of losartan and the typical adult starting dose for hypertension?
What is Poncet’s disease?
What is the appropriate prednisone taper regimen for an adult with pneumonitis starting at 60 mg daily?
What new clinical trials or second‑line therapies are available for a patient with metastatic testicular germ‑cell tumor refractory to standard BEP (bleomycin, etoposide, cisplatin) chemotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.